Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
Critical Reviews™ in Immunology
Fator do impacto: 1.352 FI de cinco anos: 3.347 SJR: 0.657 SNIP: 0.55 CiteScore™: 2.19

ISSN Imprimir: 1040-8401
ISSN On-line: 2162-6472

Volumes:
Volume 39, 2019 Volume 38, 2018 Volume 37, 2017 Volume 36, 2016 Volume 35, 2015 Volume 34, 2014 Volume 33, 2013 Volume 32, 2012 Volume 31, 2011 Volume 30, 2010 Volume 29, 2009 Volume 28, 2008 Volume 27, 2007 Volume 26, 2006 Volume 25, 2005 Volume 24, 2004 Volume 23, 2003 Volume 22, 2002 Volume 21, 2001 Volume 20, 2000 Volume 19, 1999 Volume 18, 1998 Volume 17, 1997 Volume 16, 1996 Volume 15, 1995 Volume 14, 1994

Critical Reviews™ in Immunology

DOI: 10.1615/CritRevImmunol.v21.i1-3.40
18 pages

T-Cell Receptor-Derived Peptides in Immunoregulation and Therapy of Retrovirally Induced Immunosuppression

John J. Marchalonis
Department of Immunobiology, University of Arizona College of Medicine P.O. Box 24-5049 Tucson, AZ 85724
Ian F. Robey
Arizona Cancer Center; Microbiology and Immunology, College of Medicine, University of Arizona, Tucson, AZ 85724
Allen B. Edmundson
Oklahoma Medical Research Foundation, Oklahoma City, OK 73104
R. Tomas Sepulveda
Microbiology and Immunology, College of Medicine, and College of Public Health, University of Arizona, Tucson, AZ 85724
Ronald R. Watson
2College of Public Health, University of Arizona, Tucson, AZ 85724

RESUMO

Retrovirally infected humans and mice showed progressive acquired immunodeficiency accompanied by the production of elevated levels of autoantibodies directed against T-cell receptor variable-domain epitopes. Epitope mapping analyses indicated that a major determinant recognized was defined by a 16-mer peptide containing the entire CDR1 segment and part of the FR2 region of human Vb8, and that both species showed reactivity to the same sequence. Either prophylactic or therapeutic administration of this peptide to retrovirusinfected C57/BL/6 mice normalized the balance of TH1- and TH2-type helper activity and restored the resistance to infection by the opportunistic parasite Cryptosporidium. Administration of the peptide did not generate significantly increased levels of autoantibody, but had a profound effect on T-cell activity as well as other aspects of inflammation, including NK-cell activity. A 16-mer derived from the Jb sequence showed similar functional effects on T cells from retrovirus-infected mice. Direct binding of the Vb CDR1 peptide to recombinant TCR Va/Vb constructs, as well as to IgM natural autoantibodies, suggests that the cell surface receptor for the peptide is the a/b TCR on T cells and surface IgM in B cells. The Vb CDR1 peptide stimulated division of murine splenocytes in vitro, stimulated the production of the TH1 cytokine IL-2, and synergized with the T-cell mitogen concanavalin A in proliferation and IL-2 production. These studies indicate that administration of peptides derived from T-cell receptor variable domains to animals immunosuppressed as a result of retroviral infection has a profound immunomodulatory effect enhancing overall T-cell functional capacity, particularly with respect to the cytokine production characteristic of TH1-type cells. Our studies are interpreted in the context of other recent investigations of immunomodulatory peptides.


Articles with similar content:

Role of Peroxisome Proliferator-Activated Receptor g and Its Ligands in the Control of Immune Responses
Critical Reviews™ in Immunology, Vol.23, 2003, issue 1-2
Alessio Nencioni, Peter Brossart, Sebastian Wesselborg
Prostaglandins and the Regulation of Tumor Growth
Journal of Environmental Pathology, Toxicology and Oncology, Vol.21, 2002, issue 2
Jane A. Mitchell, Timothy D. Warner, David Bishop-Bailey, Timothy Hla, Sara Calatayud
Targeting the Antigen-Binding Site of HLA-Restricting Alleles in Treatment of Autoimmune Disease
Critical Reviews™ in Immunology, Vol.27, 2007, issue 3
Philip Deitiker, M. Zouhair Atassi, Minako Oshima
PART III. Autoimmunity
An Altered Peptide Ligand of Type II Collagen Suppresses Autoimmune Arthritis

Critical Reviews™ in Immunology, Vol.27, 2007, issue 4
Linda K. Myers, Edward F. Rosioniec, Andrew H. Kang, Bo Tang, John M. Stuart
Th1-Oriented Immunomodulating Activity of Gel-Forming Fungal (1®3)-Beta-Glucans
International Journal of Medicinal Mushrooms, Vol.4, 2002, issue 2
Toshiro Yadomae, Naohito Ohno, Takafumi Jinushi